Article
Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.
Cancer letters - 10 Jul 2017
Shih Yi-Ping, Yuan Sarah Y, Lo Su Hao
Abstract excerpt
DLC1 is a RhoGAP-containing tumor suppressor that inhibits angiogenesis by repressing VEGF production in epithelial cells. Here we report the roles of DLC1 in endothelial cells. Silencing of DLC1 (siDLC1) enhances cell migration but reduces tube formation activities of human umbilical vein endothelial cells (HUVECs). Biochemically, RhoA activity and paxillin protein level are markedly increased in siDLC1 HUVECs....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
